Gilenya Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Condition:   Multiple Sclerosis (MS) Interventions:   Drug: Fingolimod;   Drug: Ofatumumab;   Drug: Siponimod;   Other: Fingolimod placebo;   Other: Siponimod placebo;   Other: Ofatumumab placebo Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2021 Category: Research Source Type: clinical trials

Revascularization Pretreated With Fingolimod in Acute Stroke
Condition:   Stroke Interventions:   Drug: Fingolimod;   Drug: placebo Sponsor:   The Affiliated Hospital of Xuzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials